Another Award I Nominate Me For: PM360’s Trailblazer Award
Regular Readers of Pharma Marketing Blog may know that I nominated myself for PMLiVE's Healthcare Communiquétor Award (see here). I now followup by nominating myself for PM360's "Trailblazer" Award.
With regard to...
Do TV DTC Ads Overstate Rx Drug Risks? FDA May Make Changes that Put...
Balancing drug benefits (efficacy) against risks in direct-to-consumer (DTC) advertising has always been a contentious issue between pharma marketers and the FDA. About 40% of violations in drug ads cited by...
Pharmalot R.I.P. Redux: Thoughts on Ed Silverman Joining Rupert Murdoch’s WSJ Blogosphere
In case you haven't heard, Ed Silverman -- former creator and writer of Pharmalot blog -- has joined The Wall Street Journal pharma/health team & will blog there.
Scott Hensley formerly of...
I Nominate Me for Healthcare Communiquétor: Who Seconds?
The Communiqué Awards 2014 are open for entry! "This award recognises outstanding personal achievement at a very senior level in healthcare communications. It is open to professionals currently working in industry...
What the “Flappy Bird” Story Can Teach Pharma Game Developers
By now everyone has heard how the developer of "Flappy Bird" pulled the mobile game from the Apple and Google app stores because it was "too addictive."
"I just wanted to create...
Boehringer Ingelheim’s High Ranking in Social Media Patient Engagement vs. Shameful Real Life Anti-Patient...
Just because a pharma company gets kudos for engaging with and supporting patients via Social Media does not mean the company always has patients' interests at heart and will put patent...
A Pharma Marketing “Bait-and-Switch” Scheme: Sales Reps Disguised as Medical Science Liaisons
Celgene was accused of promoting its cancer drug Thalomid and related compound Revlimid for uses not approved by U.S. regulators in a newly unsealed lawsuit filed by Beverly Brown, an ex-"saleswoman"...
FDA’s 2014 Social Media Guidance Agenda Published: Space Limitation, Correcting Third Party Misinformation, &...
The FDA has just published its "Guidance Agenda: New & Revised Draft Guidances CDER is Planning to Publish During Calendar Year 2014," which includes these promised guidances under the "Advertising" category:
Brief...
Big Government’s Big Data Push: Like NSA, FDA is Collecting Massive Amounts of Data...
FDA's "Mini-Sentinel" project released a report on the massive amounts of personally-identifiable health data it is collecting about 160 million patients.
According to Alec Gaffney's summary of the report:
"As of July 2012,...
2014 Edition of The Pharmaguy Social Media Timeline™
Now that the FDA has finally published a bit of its long-awaited social media guidelines for the drug industry, I thought it would be a good idea to update The Pharmaguy...
